Heteroaryl carboxamides

US10487079B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Martin Hendrix · Tarrytown, US
• Frank-Gerhard Böβ · Grafton, GB
• Christina Erb · Wiesbaden, DE
• Joachim Krüger · Mülheim an der Ruhr, DE
• Christoph Methfessel · Wuppertal, DE
• Rudy Schreiber · Menlo Park, US
• Welf-Burkhard Wiese · Langenfeld, DE
• Joachim Luithle · Wülfrath, DE

Key dates

• Filing date: Feb 27, 2018
• Grant date: Nov 26, 2019
• Expiry date: Feb 27, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel heteroaryl carboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.